HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition.

AbstractBACKGROUND:
Providing the correct diagnosis for patients with tubulointerstitial kidney disease and secondary degenerative disorders, such as hypertension, remains a challenge. The autosomal dominant tubulointerstitial kidney disease (ADTKD) subtype caused by MUC1 mutations (ADTKD-MUC1) is particularly difficult to diagnose, because the mutational hotspot is a complex repeat domain, inaccessible with routine sequencing techniques. Here, we further evaluated SNaPshot minisequencing as a technique for diagnosing ADTKD-MUC1 and assessed immunodetection of the disease-associated mucin 1 frameshift protein (MUC1-fs) as a nongenetic technique.
METHODS:
We re-evaluated detection of MUC1 mutations by targeted repeat enrichment and SNaPshot minisequencing by haplotype reconstruction via microsatellite analysis in three independent ADTKD-MUC1 families. Additionally, we generated rabbit polyclonal antibodies against MUC1-fs and evaluated immunodetection of wild-type and mutated allele products in human kidney biopsy specimens.
RESULTS:
The detection of MUC1 mutations by SNaPshot minisequencing was robust. Immunostaining with our MUC1-fs antibodies and an MUC1 antibody showed that both proteins are readily detectable in human ADTKD-MUC1 kidneys, with mucin 1 localized to the apical membrane and MUC1-fs abundantly distributed throughout the cytoplasm. Notably, immunohistochemical analysis of MUC1-fs expression in clinical kidney samples facilitated reliable prediction of the disease status of individual patients.
CONCLUSIONS:
Diagnosing ADTKD-MUC1 by molecular genetics is possible, but it is technically demanding and labor intensive. However, immunohistochemistry on kidney biopsy specimens is feasible for nongenetic diagnosis of ADTKD-MUC1 and therefore, a valid method to select families for further diagnostics. Our data are compatible with the hypothesis that specific molecular effects of MUC1-fs underlie the pathogenesis of this disease.
AuthorsKarl X Knaup, Thomas Hackenbeck, Bernt Popp, Johanna Stoeckert, Andrea Wenzel, Maike Büttner-Herold, Frederick Pfister, Markus Schueler, Didem Seven, Annette M May, Jan Halbritter, Hermann-Josef Gröne, André Reis, Bodo B Beck, Kerstin Amann, Arif B Ekici, Michael S Wiesener
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 29 Issue 9 Pg. 2298-2309 (09 2018) ISSN: 1533-3450 [Electronic] United States
PMID30049680 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 by the American Society of Nephrology.
Chemical References
  • MUC1 protein, human
  • Mucin-1
Topics
  • Adult
  • Alleles
  • Animals
  • Biopsy, Needle
  • Cohort Studies
  • Female
  • Gene Expression Regulation, Developmental
  • Genetic Predisposition to Disease (epidemiology)
  • Haplotypes
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Mucin-1 (genetics)
  • Mutation (genetics)
  • Nephritis, Interstitial (genetics, pathology)
  • Pedigree
  • Polycystic Kidney, Autosomal Dominant (genetics, pathology)
  • Rabbits
  • Retrospective Studies
  • Risk Assessment
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: